Dyslipidemia can be an important risk element for coronary disease (CVD) and atherosclerosis. This review discusses the systems of metabolic rules by FXR and TGR5 as well as the energy relevance of organic and artificial modulators of FXR and TGR5 activity, including bile acidity sequestrants, in the treating the MS. N-terminal kinase (JNK) (20, 21).… Continue reading Dyslipidemia can be an important risk element for coronary disease (CVD)